My GP surgery said I had a cold but it was thyroid cancer and listening to my instincts saved me. Now read the definitive guide to thyroids - and how to know if something's wrong with yours
When Abi Phillips thinks over the last couple of years, it is not with fondness of the good times. While her friends were busy with their lives, Abi was being treated for cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - May 23, 2024 Category: Consumer Health News Source Type: news

More Evidence Supports Active Surveillance for Low-Risk Papillary Thyroid Cancer
(MedPage Today) -- Conversion surgery after active surveillance for low-risk papillary thyroid carcinoma (PTC) led to no clinically meaningful differences in outcomes as compared with immediate surgery, according to a matched cohort study. Complication... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 17, 2024 Category: Endocrinology Source Type: news

The Land That Doesn ’ t Need Ozempic
In March 2023, the Japanese medical authorities announced that the new weight loss drug Wegovy—which was in staggering demand across the world, causing shortages everywhere—had been approved to treat obesity in their country. It sounded, at first glance, like great news for Novo Nordisk, the company that makes Ozempic and Wegovy. But industry outlet the Pharma Letter explained that this would not in fact turn out to be much of a boost. They predicted that these drugs would dominate the market in Japan, but that won’t mean much, for a simple reason: there is almost no obesity there. Some 42% of Americans a...
Source: TIME: Health - May 9, 2024 Category: Consumer Health News Authors: Johann Hari Tags: Uncategorized Books freelance Source Type: news

Is Ozempic the New Anti-Inflammatory Wonder Drug?
Nearly a decade ago, a thin, soft-spoken twenty-something woman named Megan walked into my office and presented me with a meticulous hand-written file containing her gastrointestinal history. The file included descriptions of her initial diagnosis of Crohn’s disease as a teenager, the multiple operations she had endured to remove diseased parts of her bowels, and the array of symptoms she suffered with, including nausea, a dozen bowel movements a day, and a total reliance on nutrition obtained through her veins, known as total parenteral nutrition (TPN). Instead of twenty feet of small intestines that most people hav...
Source: TIME: Health - April 30, 2024 Category: Consumer Health News Authors: Shilpa Ravella Tags: Uncategorized freelance Source Type: news

GLP1 Receptor Agonist Use Does Not Seem to Increase Risk for Thyroid Cancer
WEDNESDAY, April 24, 2024 -- Glucagon-like peptide 1 (GLP1) receptor agonist use does not appear to be associated with an increased risk for thyroid cancer, according to a study published online April 10 in The BMJ. Björn Pasternak, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 24, 2024 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19
Group sales grew by 2%1 at constant exchange rates (CER) (-6% in CHF), driven by the strong growth of newer medicines and diagnostics. Excluding COVID-19-related products, sales increased by 7%. Going forward, there will be no further material impact of COVID-19 sales declineDue to the appreciation of the Swiss franc against most currencies,saleswere 6% lower when reported in CHFPharmaceuticals Divisionbase business2 grew by 7%, driven by strong sales of medicines to treat severe diseases, such as Vabysmo (eye diseases), Phesgo (breast cancer), Ocrevus (multiple sclerosis), Polivy (blood cancer) and Hemlibra (haemophilia A...
Source: Roche Investor Update - April 24, 2024 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19
Group sales grew by 2%1 at constant exchange rates (CER) (-6% in CHF), driven by the strong growth of newer medicines and diagnostics. Excluding COVID-19-related products, sales increased by 7%. Going forward, there will be no further material impact of COVID-19 sales declineDue to the appreciation of the Swiss franc against most currencies,saleswere 6% lower when reported in CHFPharmaceuticals Divisionbase business2 grew by 7%, driven by strong sales of medicines to treat severe diseases, such as Vabysmo (eye diseases), Phesgo (breast cancer), Ocrevus (multiple sclerosis), Polivy (blood cancer) and Hemlibra (haemophilia A...
Source: Roche Media News - April 24, 2024 Category: Pharmaceuticals Source Type: news

Microwave Ablation Feasible for T1N0M0 Papillary Thyroid Carcinoma
FRIDAY, April 12, 2024 -- For patients with multifocal papillary thyroid carcinoma (PTC), the rates of progression-free survival (PFS) do not differ between microwave ablation (MWA) and surgical resection (SR), according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 12, 2024 Category: Pharmaceuticals Source Type: news

GLP-1 Receptor Agonists Don't Raise Thyroid Cancer Risk GLP-1 Receptor Agonists Don't Raise Thyroid Cancer Risk
A cohort study in three Scandinavian countries found no significant increase in thyroid cancer risk with glucagon-like peptide 1 receptor agonists.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 12, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Clinical Summary Source Type: news

Study Assuages Thyroid Cancer Fears With GLP-1 Receptor Agonists
(MedPage Today) -- A Scandinavian cohort study suggested a popular class of diabetes drug did not put patients at an elevated risk for thyroid cancer, a longtime lingering concern with this drug class. Compared with DPP-4 inhibitors, patients... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - April 10, 2024 Category: Urology & Nephrology Source Type: news

Taylor Swift Is Embracing the 5 Stages of Grief. Should You?
Call it the Five Stages of Grief (Taylor’s Version). Last week, ahead of the release of her album The Tortured Poets Department, Taylor Swift shared five new playlists that sort her old songs into stages: denial, anger, bargaining, depression, and acceptance. “These songs represent making room for more good in your life,” she says in a brief audio message accompanying the final playlist, acceptance. “Making that choice. Because a lot of time when we lose things, we gain things too.” [time-brightcove not-tgx=”true”] In the two months since Swift announced her new album, which co...
Source: TIME: Health - April 10, 2024 Category: Consumer Health News Authors: Angela Haupt Tags: Uncategorized Evergreen healthscienceclimate Source Type: news

Ozempic, Wegovy Won't Boost Thyroid Cancer Risk: Study
WEDNESDAY, April 10, 2024 -- Wegovy, Ozempic and other drugs known as GLP-1 analogues have become wildly popular for controlling diabetes and helping folks lose weight. There were concerns that longer term use of the drugs might raise users ' odds... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 10, 2024 Category: General Medicine Source Type: news

UltraCon: Microflow imaging on par with CEUS for guiding tumor ablation
AUSTIN -- Microflow imaging performs just as well as contrast-enhanced ultrasound (CEUS) for guiding tumor ablation and may be an economical alternative, according to research presented April 8 at UltraCon. In her talk, Ziyue Hu, MD, from Sichuan Cancer Hospital in China highlighted findings showing that along with yielding comparable performance in treating thyroid nodules, microflow imaging in this area is less costly and invasive than CEUS. “We found that in the microwave ablation procedure for thyroid nodules that … microflow imaging offers the advantages of reducing surgical expenses, which lessens the economic ...
Source: AuntMinnie.com Headlines - April 9, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Source Type: news

Unleashing CAR-T cell therapy to destroy solid tumors in thyroid cancer
Mayo Clinic researchers will jump four hurdles to apply chimeric antigen receptor-T cell therapy (CAR-T cell therapy) to solid tumors in thyroid cancer. This regenerative immunotherapy has shown promising results in blood cancers, and new research is focused on using this treatment on more types of malignancies. "CAR-T cell therapy is unlike other therapeutics," says Saad Kenderian, M.B., Ch.B., a hematologist and cancer researcher. "Other therapies may slow down cancer. CAR-T cell therapy has shown… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 9, 2024 Category: Databases & Libraries Source Type: news

The rise of theranostics: Part 2 -- Moving into communities
A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. That has changed and the field of theranostics is expanding rapidly in various ways, as described in part 1 of AuntMinnie.com's series on the rise of theranostics. However, few freestanding theranostics centers exist today. Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. They're also mindful of the multiple dedicated teams required to build a thera...
Source: AuntMinnie.com Headlines - April 4, 2024 Category: Radiology Authors: Liz Carey Tags: Practice Management Radiation Oncology/Therapy Nuclear Medicine Medicolegal Genitourinary Radiology Source Type: news